APA (7th ed.) Citation

Bi, D., Apter, D., Eriksson, T., Hokkanen, M., Zima, J., Damaso, S., . . . Struyf, F. (2020). Safety of the AS04-adjuvanted human papillomavirus (HPV)-16/18 vaccine in adolescents aged 12–15 years: End-of-study results from a community-randomized study up to 6.5 years. Taylor & Francis Group.

Chicago Style (17th ed.) Citation

Bi, Dan, et al. Safety of the AS04-adjuvanted Human Papillomavirus (HPV)-16/18 Vaccine in Adolescents Aged 12–15 Years: End-of-study Results from a Community-randomized Study Up to 6.5 Years. Taylor & Francis Group, 2020.

MLA (9th ed.) Citation

Bi, Dan, et al. Safety of the AS04-adjuvanted Human Papillomavirus (HPV)-16/18 Vaccine in Adolescents Aged 12–15 Years: End-of-study Results from a Community-randomized Study Up to 6.5 Years. Taylor & Francis Group, 2020.